Literature DB >> 2557877

Effects of antihypertensive agents on endothelium-dependent and endothelium-independent relaxations.

P J Shultz1, L Raij.   

Abstract

1. Antihypertensive agents normalize blood pressure and restore depressed endothelium-dependent relaxations in experimental models of hypertension, but little is known regarding whether antihypertensive agents themselves can directly modulate responses to agonists of endothelium-dependent or independent relaxations, or contractions. 2. Normal rats were treated with either tap water, captopril, hydralazine or enalapril in their drinking water for 2 weeks, following which endothelium-dependent and endothelium-independent relaxations were tested with acetylcholine and sodium nitroprusside, respectively, in aortic rings suspended in organ chambers. 3. All antihypertensive agents caused slight but similar potentiation of sodium nitroprusside-induced relaxations. However, their effects on acetylcholine-induced relaxations were quite different: captopril had a marked potentiating effect, hydrazaline a slight potentiating effect, and enalapril had no significant effect on these relaxations. 4. The relaxations induced by acetylcholine and potentiated by captopril were not altered when indomethacin was included in the tissue bath. However, pyrogallol, an inhibitor of endothelium-derived relaxing factor (EDRF), markedly inhibited these relaxations suggesting that captopril's effect may involve EDRF. 5. SQ 14,534, a stereoisomer of captopril which is 100 fold less potent in inhibiting angiotensin converting enzyme, also significantly enhanced acetylcholine induced relaxations. Thus the effects of both captopril and SQ 14,534 upon EDRF appear independent of the effects of these compounds on the angiotensin converting enzyme. 6. We conclude that certain antihypertensive agents may modulate endothelium-dependent relaxations in response to agonists, and that these properties may be of therapeutic importance in cardiovascular diseases.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2557877      PMCID: PMC1379857          DOI: 10.1111/j.1365-2125.1989.tb03590.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  18 in total

Review 1.  Angiotensin-converting enzyme inhibitors. Emerging differences and new compounds.

Authors:  J B Kostis
Journal:  Am J Hypertens       Date:  1989-01       Impact factor: 2.689

2.  Pharmacological evidence that endothelium-derived relaxing factor is nitric oxide: use of pyrogallol and superoxide dismutase to study endothelium-dependent and nitric oxide-elicited vascular smooth muscle relaxation.

Authors:  L J Ignarro; R E Byrns; G M Buga; K S Wood; G Chaudhuri
Journal:  J Pharmacol Exp Ther       Date:  1988-01       Impact factor: 4.030

3.  Selective attenuation of endothelium-mediated vasodilation in atherosclerotic human coronary arteries.

Authors:  U Förstermann; A Mügge; U Alheid; A Haverich; J C Frölich
Journal:  Circ Res       Date:  1988-02       Impact factor: 17.367

4.  Atherosclerosis impairs endothelium-dependent vascular relaxation to acetylcholine and thrombin in primates.

Authors:  P C Freiman; G G Mitchell; D D Heistad; M L Armstrong; D G Harrison
Journal:  Circ Res       Date:  1986-06       Impact factor: 17.367

Review 5.  Modulation of vascular smooth muscle contraction by the endothelium.

Authors:  P M Vanhoutte; G M Rubanyi; V M Miller; D S Houston
Journal:  Annu Rev Physiol       Date:  1986       Impact factor: 19.318

6.  The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide.

Authors:  M W Radomski; R M Palmer; S Moncada
Journal:  Br J Pharmacol       Date:  1987-11       Impact factor: 8.739

7.  Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor.

Authors:  R J Gryglewski; R M Palmer; S Moncada
Journal:  Nature       Date:  1986 Apr 3-9       Impact factor: 49.962

8.  Direct scavenging of free radicals by captopril, an angiotensin converting enzyme inhibitor.

Authors:  D Bagchi; R Prasad; D K Das
Journal:  Biochem Biophys Res Commun       Date:  1989-01-16       Impact factor: 3.575

9.  Endothelium-dependent vascular responses in normotensive and hypertensive Dahl rats.

Authors:  T F Lüscher; L Raij; P M Vanhoutte
Journal:  Hypertension       Date:  1987-02       Impact factor: 10.190

10.  Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor.

Authors:  R M Palmer; A G Ferrige; S Moncada
Journal:  Nature       Date:  1987 Jun 11-17       Impact factor: 49.962

View more
  4 in total

1.  Chronic treatment with the angiotensin I converting enzyme inhibitor, perindopril, protects in vitro carbachol-induced vasorelaxation in a rat model of vascular calcium overload.

Authors:  D Henrion; J M Chillon; C Capdeville-Atkinson; M Vinceneux-Feugier; J Atkinson
Journal:  Br J Pharmacol       Date:  1991-12       Impact factor: 8.739

Review 2.  Cardioprotective effect of angiotensin-converting enzyme inhibitors in patients with coronary artery disease.

Authors:  R Ferrari; C Ceconi; S Curello; P Pepi; A Mazzoletti; O Visioli
Journal:  Cardiovasc Drugs Ther       Date:  1996-11       Impact factor: 3.727

Review 3.  Endothelial vasomotor regulation in health and disease.

Authors:  N R Searle; P Sahab
Journal:  Can J Anaesth       Date:  1992-10       Impact factor: 5.063

Review 4.  Factors regulating the renal circulation in spontaneously hypertensive rats.

Authors:  Ahmad F Ahmeda; Mohammed Alzoghaibi
Journal:  Saudi J Biol Sci       Date:  2015-06-26       Impact factor: 4.219

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.